Inactive Instrument

Redsense Medical AB (publ) Stock Nasdaq Stockholm

Equities

Medical Equipment, Supplies & Distribution

End-of-day quote Nasdaq Stockholm
- - Intraday chart for Redsense Medical AB (publ)
Sales 2022 16.75M 1.55M 0 Sales 2023 25.52M 2.36M 0 Capitalization 107M 9.87M 0
Net income 2022 -8M -740K - Net income 2023 -4M -370K - EV / Sales 2022 7.31 x
Net cash position 2022 10.58M 978K 0 Net cash position 2023 6.97M 644K 0 EV / Sales 2023 3.91 x
P/E ratio 2022
-15.2 x
P/E ratio 2023
-23.8 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 100%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 60 22-04-30
Director of Finance/CFO - 22-12-31
Chief Operating Officer - 16-05-31
Members of the board TitleAgeSince
Director/Board Member 53 12-12-31
Chairman 61 22-12-31
Director/Board Member - 22-12-31
More insiders
Redsense Medical AB (publ) is a Sweden-based company, which is primarily involved in the healthcare industry. The Company is active within the field of hemodialysis. It operates as a manufacturer of blood loss detection device that is designed to alarm on blood leakage from the venous blood access. The Company's Redsense system consists of an alarm unit, an extension fiber and a non invasive sensor patch. When the sensor patch is placed over the blood access, it detects any blood coming in contact with the sensor. This can occur if the needle is accidentally dislodged or if blood is leaking during dialysis. The Redsense system is designed to alarm when blood reaches the sensor, so the dialysis caregiver or observing person at home, can apply appropriate action when a venous needle dislodges.
Calendar
More about the company